CAMI for Substance Use
(CAMI-HI Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a culturally adapted motivational interviewing method to help Latinx heavy drinkers who face immigration-related stress. The study aims to see if this approach reduces alcohol use and improves mental health. It will also explore how well this method can be implemented in real-world clinical settings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It would be best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment CAMI for Substance Use?
Research shows that Culturally Adapted Motivational Interviewing (CAMI) can be effective in reducing heavy drinking among Latinx adults by addressing cultural stressors. A systematic review found that CAMI performed better than control conditions in several studies, suggesting it can be a helpful approach for substance use issues in diverse populations.12345
Is Culturally Adapted Motivational Interviewing (CAMI) safe for humans?
How is the CAMI treatment different from other treatments for substance use?
Research Team
Christina S Lee, PhD
Principal Investigator
Boston University
Eligibility Criteria
This trial is for Latinx adults who are first or second-generation immigrants and heavy drinkers, defined as having 4/5 or more drinks per occasion at least once a month, or scoring high on alcohol use assessments. It's not for those in current treatment for alcohol disorders, with psychotic symptoms, cognitive impairments, or enrolled in the CCM Program for over 3 months.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single 75-minute CAMI session focusing on addiction behavior causes, followed by a booster session at 2 months
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of drinking and drug use, anxiety, and depression
Treatment Details
Interventions
- CAMI (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor
Dr. Melissa Gilliam
Boston University Charles River Campus
Chief Executive Officer
MD from Yale School of Medicine
Dr. Alastair Bell
Boston University Charles River Campus
Chief Medical Officer since 2023
MD from Harvard Medical School
Brown University
Collaborator
Mukesh Jain
Brown University
Chief Medical Officer since 2022
MD from Harvard Medical School
Christina H. Paxson
Brown University
Chief Executive Officer since 2012
PhD in Economics from Columbia University
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator
Dr. George F. Koob
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Executive Officer since 2014
PhD in Neurobiology from the Scripps Research Institute
Dr. Patricia Powell
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Chief Medical Officer since 2015
MD from an accredited institution